Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Natalia Pozhidaeva
Real-World Study of Efficacy, Risk Management and Reasons for Discontinuation of Natalizumab for Treatment of Multiple Sclerosis in Russia
PLoS ONE
Multidisciplinary
Related publications
Efficacy of Natalizumab and Fingolimod in Relapsing Remitting Multiple Sclerosis in Real World Clinical Setting
Journal of Neurology & Neurophysiology
Natalizumab Treatment in Multiple Sclerosis
Clinical Neurology
Neurology
Natalizumab: A New Treatment for Relapsing Remitting Multiple Sclerosis
Therapeutics and Clinical Risk Management
Chemical Health
Pharmacology
Safety
Medicine
Toxicology
Safety Research
Pharmaceutics
Natalizumab Versus Fingolimod and Dimethyl Fumarate in Multiple Sclerosis Treatment
Annals of Clinical and Translational Neurology
Neuroscience
Neurology
Natalizumab Therapy for Highly Active Pediatric Multiple Sclerosis
JAMA Neurology
Neurology
Clinical Effects of Natalizumab on Multiple Sclerosis Appear Early in Treatment Course
Journal of Neurology
Neurology
Evolution of MRI Appearances Due to Progressive Multifocal Leucoencephalopathy Following Natalizumab Treatment for Multiple Sclerosis
BMJ Case Reports
Medicine
Real-Life Effectiveness of Natalizumab in Relapsing-Remitting Multiple Sclerosis (Rrms): A Registry Analysis
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
A Randomized, Placebo-Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis
New England Journal of Medicine
Medicine